NEWS
CENTER
NEWS CENTER
Let ECG enter households and save billions patients with cardiovascular disease.
News Center
-
Better Science, Better Health, Deep Dive into Home Use ECG Market—The 3rd-generation of the Wireless Heartpal ECG device has been officially launched
Weheal Inc., a medical device company funded and incubated by Baheal Pharma Group, with a focus on innovative cardiovascular disease technology, has unveiled its latest product - the 3rd-generation Heartpal ECG Device.
-
The commercial edition of Heartpal 12-lead ECG has been implemented in over 5,000 clinics, containing more than 180,000 records of ECG data.
Since 2018, in collaboration with various pharmaceutical companies, we have rolled out the clinical version of the ECG device and patient management systems to over 5,000 primary medical institutions,
-
Remote Emergency Rescue Case of Acute Myocardial Infarction
Medical Intervention: The doctor on duty received a critical alert and promptly contacted the patient by phone. The patient, located at a clinic near his residence, had just completed an ECG using the first-generation Heartpal ECG Device.
-
Case of Remote Assistance for Arrhythmia
palpitations recently and visited a nearby clinic. The EKG test revealed atrial fibrillation. The doctor recommended thatthe patient should go to a nearby large hospital for further examination and treatment as soon as possible.
